- Home
- TCBK vs OCUL Comparison
TCBK vs OCUL Comparison
Compare TCBK & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBK
- OCUL
- Stock Information
- Founded
- TCBK 1975
- OCUL 2006
- Country
- TCBK United States
- OCUL United States
- Employees
- TCBK N/A
- OCUL N/A
- Industry
- TCBK Major Banks
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- TCBK Finance
- OCUL Health Care
- Exchange
- TCBK Nasdaq
- OCUL Nasdaq
- Market Cap
- TCBK 1.4B
- OCUL 1.4B
- IPO Year
- TCBK N/A
- OCUL 2014
- Fundamental
- Price
- TCBK $44.45
- OCUL $8.50
- Analyst Decision
- TCBK Buy
- OCUL Strong Buy
- Analyst Count
- TCBK 6
- OCUL 8
- Target Price
- TCBK $48.20
- OCUL $16.50
- AVG Volume (30 Days)
- TCBK 138.1K
- OCUL 891.4K
- Earning Date
- TCBK 01-23-2025
- OCUL 11-14-2024
- Dividend Yield
- TCBK 2.97%
- OCUL N/A
- EPS Growth
- TCBK N/A
- OCUL N/A
- EPS
- TCBK 3.36
- OCUL N/A
- Revenue
- TCBK $387,200,000.00
- OCUL $61,442,000.00
- Revenue This Year
- TCBK N/A
- OCUL $11.40
- Revenue Next Year
- TCBK $3.74
- OCUL $13.58
- P/E Ratio
- TCBK $13.23
- OCUL N/A
- Revenue Growth
- TCBK N/A
- OCUL 6.45
- 52 Week Low
- TCBK $31.73
- OCUL $3.76
- 52 Week High
- TCBK $51.06
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- TCBK 37.16
- OCUL 38.29
- Support Level
- TCBK $43.62
- OCUL $8.15
- Resistance Level
- TCBK $49.71
- OCUL $9.21
- Average True Range (ATR)
- TCBK 1.32
- OCUL 0.48
- MACD
- TCBK -0.66
- OCUL -0.07
- Stochastic Oscillator
- TCBK 15.43
- OCUL 16.99
About TCBK TriCo Bancshares
TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of Treasury Management Services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.